Importance of Patent Injunctions Depends on Industry
Initial briefs in this case are due January 14, 2006. Oral argument could take place in March 2006, with a ruling sometime in June.
[T]he availability of injunctive relief in patent cases differentially impacts the
patent portfolio management strategies of high-technology and pharmaceutical
companies. Pharmaceutical companies tend to favor the current rule, as
injunctions provide them with a powerful form of relief for halting
infringement. High-technology companies, on the other hand, tend to disfavor the
current rule, because their individual products often incorporate many
technologies. Thus, high-technology companies tend to fear opportunistic
lawsuits by parties who use the threat of injunction as leverage in resolution
of patent disputes.